🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.40745
-0.0446 (-9.86%)
At close: Nov 20, 2026, 4:00 PM EST
0.4170
+0.0096 (2.34%)
After-hours: Nov 20, 2026, 7:30 PM EST

Daré Bioscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
0.050.190.151.020-0.020.03-0.060.040.020.011.811----10--
Revenue Growth (YoY)
2005.57%-499.58%--94.57%-173.35%--95.83%-----------
Cost of Revenue
0.180.560.9-4.611.181.432.3-10.982.68-3.3621.560.030.030.0330.070.030.030.030.03
Gross Profit
-0.13-0.37-0.755.63-1.17-1.45-2.2710.91-2.640.02-3.35-19.760.98-0.03-0.03-30.07-0.039.98-0.03-0.03
Selling, General & Admin
2.642.592.251.582.52.382.3122.042.452.672.952.72.923.343.232.652.792.572.4
Research & Development
0.32--5.52---14.31-4.93--17.746.676.045.02-17.074.466.85.817.12
Operating Expenses
2.962.592.257.12.52.382.3116.32.047.382.67-14.789.378.968.36-13.847.119.598.389.52
Operating Income
-3.09-2.97-3-1.47-3.67-3.83-4.58-5.39-4.68-7.36-6.02-4.97-8.4-8.99-8.38-16.23-7.140.38-8.4-9.54
Other Non Operating Income (Expenses)
-0.07-0.01-00.030.11-0.190.2-0.12-0.0220.27-0.730.110.10.230.340.290.120.0300
EBT Excluding Unusual Items
-3.16-2.98-3-1.44-3.56-4.02-4.38-5.51-4.712.91-6.76-4.86-8.3-8.76-8.04-15.94-7.020.41-8.4-9.54
Other Unusual Items
------------0.4--------
Pretax Income
-3.16-2.98-3-1.44-3.56-4.02-4.38-5.51-4.712.91-6.76-5.06-8.3-8.76-8.04-15.94-7.020.41-8.4-9.54
Net Income
-3.16-2.98-3-1.44-3.56-4.02-4.38-5.51-4.712.91-6.76-5.06-8.3-8.76-8.04-15.94-7.020.41-8.4-9.54
Net Income to Common
-3.16-2.98-3-1.44-3.56-4.02-4.38-5.51-4.712.91-6.76-5.06-8.3-8.76-8.04-15.94-7.020.41-8.4-9.54
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
1715151413998988787777774
Shares Outstanding (Diluted)
1715151413998988787777774
Shares Change (YoY)
36.59%67.84%65.80%78.14%49.45%4.66%4.57%9.92%12.48%17.72%17.54%7.26%7.34%1.21%1.87%56.89%19.85%69.26%88.63%36.12%
EPS (Basic)
-0.18-0.20-0.21-0.10-0.28-0.45-0.50-0.69-0.551.53-0.81-0.69-1.09-1.22-1.13-2.34-0.990.06-1.20-2.20
EPS (Diluted)
-0.18-0.20-0.21-0.10-0.28-0.45-0.50-0.69-0.551.52-0.81-0.70-1.09-1.22-1.13-2.34-0.990.06-1.20-2.20
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
-7.05-6.86-5.521.24-0.62-5.26-5.634.74-5.6412.62-6.82-8.79-8-6.59-16.12-5.98.55-8.45-12.35-9.92
Free Cash Flow Per Share
-0.41-0.46-0.380.09-0.05-0.59-0.640.59-0.661.49-0.81-1.20-1.05-0.92-2.26-0.871.21-1.19-1.76-2.29
Gross Margin
-278.94%-199.58%-549.90%-----100.00%--97.50%----99.75%--
Operating Margin
-6492.28%-1582.53%-1967.07%-143.72%-162340.76%--18016.75%--11228.68%-32799.12%-64743.85%-274.99%-839.64%----3.84%--
Profit Margin
-6630.42%-1590.42%-1967.72%-140.84%-157505.13%--17219.13%--11279.42%57539.25%-72622.62%-279.75%-829.91%----4.14%--
Free Cash Flow Margin
-14803.23%-3655.44%-3621.16%120.90%-27269.54%--22133.46%--13532.32%56241.46%-73320.34%-486.00%-799.59%-----84.49%--
EBITDA
-2.58-2.4-2.44-0.94-3.19-3.37-4.41-5.38-4.67-7.34-6.01-4.96-8.39-8.98-8.37-16.22-7.140.39-8.4-9.54
EBITDA Margin
----91.52%--------274.44%-----3.90%--
D&A For EBITDA
0.510.570.550.530.480.450.180.010.010.020.010.010.010.010.010.0100.010.010.01
EBIT
-3.09-2.97-3-1.47-3.67-3.83-4.58-5.39-4.68-7.36-6.02-4.97-8.4-8.99-8.38-16.23-7.140.38-8.4-9.54
EBIT Margin
----143.72%--------274.99%-----3.84%--
Revenue as Reported
0.050.190.151.020-0.020.03-0.040.020.011.811----10--
SEC Filings: 10-K · 10-Q